(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 17.15% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.63%.
Personalis's revenue in 2025 is $80,317,000.On average, 3 Wall Street analysts forecast PSNL's revenue for 2025 to be $6,698,133,201, with the lowest PSNL revenue forecast at $6,606,441,119, and the highest PSNL revenue forecast at $6,850,303,040. On average, 3 Wall Street analysts forecast PSNL's revenue for 2026 to be $8,411,285,362, with the lowest PSNL revenue forecast at $8,128,139,503, and the highest PSNL revenue forecast at $8,974,118,674.
In 2027, PSNL is forecast to generate $11,847,787,546 in revenue, with the lowest revenue forecast at $11,295,063,418 and the highest revenue forecast at $12,400,600,350.